These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1348450)

  • 1. Molecular analysis of the chromosome 11p region in renal cell carcinomas.
    Kovacs G; Kiechle-Schwarz M; Scherer G; Kung HF
    Cell Mol Biol; 1992 Feb; 38(1):59-62. PubMed ID: 1348450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential loss of maternal alleles in sporadic Wilms' tumour.
    Pal N; Wadey RB; Buckle B; Yeomans E; Pritchard J; Cowell JK
    Oncogene; 1990 Nov; 5(11):1665-8. PubMed ID: 1980007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
    Anglard P; Tory K; Brauch H; Weiss GH; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1991 Feb; 51(4):1071-7. PubMed ID: 1671754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A third Wilms' tumor locus on chromosome 16q.
    Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
    Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
    Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater RM; Westerveld A
    Cancer Res; 1990 Jun; 50(11):3279-83. PubMed ID: 2159377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic mosaicism in normal tissues of Wilms' tumour patients.
    Chao LY; Huff V; Tomlinson G; Riccardi VM; Strong LC; Saunders GF
    Nat Genet; 1993 Feb; 3(2):127-31. PubMed ID: 8388768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas.
    Kovacs A; Storkel S; Thoenes W; Kovacs G
    J Pathol; 1992 Jul; 167(3):273-7. PubMed ID: 1381433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiating genetic events in small renal neoplasms detected by comparative genomic hybridization.
    Presti JC; Moch H; Gelb AB; Huynh D; Waldman FM
    J Urol; 1998 Oct; 160(4):1557-61. PubMed ID: 9751412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
    Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
    Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P; Telzerow P; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma.
    Zbar B; Brauch H; Talmadge C; Linehan M
    Nature; 1987 Jun 25-Jul 1; 327(6124):721-4. PubMed ID: 2885753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
    Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
    Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD; Bigler S; Dickman K; Kovacs G
    Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic mechanisms of tumor-specific loss of 11p DNA sequences in Wilms tumor.
    Dao DD; Schroeder WT; Chao LY; Kikuchi H; Strong LC; Riccardi VM; Pathak S; Nichols WW; Lewis WH; Saunders GF
    Am J Hum Genet; 1987 Aug; 41(2):202-17. PubMed ID: 3039839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma.
    Morita R; Saito S; Ishikawa J; Ogawa O; Yoshida O; Yamakawa K; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5817-20. PubMed ID: 1682036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
    Wadey RB; Pal N; Buckle B; Yeomans E; Pritchard J; Cowell JK
    Oncogene; 1990 Jun; 5(6):901-7. PubMed ID: 2163053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors.
    Schroeder WT; Chao LY; Dao DD; Strong LC; Pathak S; Riccardi V; Lewis WH; Saunders GF
    Am J Hum Genet; 1987 May; 40(5):413-20. PubMed ID: 2883892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.